Related Experiment Video
Updated: Jul 28, 2026
09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
Synthesis of RGD analogs as potential vectors for targeted drug delivery
1Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204, USA.
Bioorganic Chemistry
|February 16, 2002
Summary
Researchers developed modified RGD peptide analogs for targeted drug delivery. These analogs maintain high affinity for integrin receptors, even with attached pharmaceutical agents, showing promise for effective delivery systems.
Area of Science:
- Biochemistry and Molecular Biology
- Medicinal Chemistry
- Drug Delivery Systems
Background:
- Integrin receptors are crucial targets for drug delivery vectors.
- RGD (Arginine-Glycine-Aspartic acid) analogs exhibit high affinity for integrin receptors.
- Modifying RGD analogs is key to tethering pharmaceutical agents without compromising receptor binding.
Purpose of the Study:
- To synthesize and evaluate RGD analogs as potential vectors for targeted pharmaceutical delivery.
- To assess the impact of side chain modifications on RGD analog affinity for glycoprotein IIb/IIIa.
- To determine the feasibility of attaching pharmaceutical agents to RGD analogs for drug delivery.
Main Methods:
- Synthesis of a series of RGD analogs with diverse side chain functional groups.
- Evaluation of RGD analogs' ability to inhibit platelet aggregation via glycoprotein IIb/IIIa binding.
- Determination of IC50 values for RGD analogs against ADP-activated platelets.
Main Results:
- Compound 11 demonstrated the lowest IC50 against ADP-activated platelets, indicating potent inhibition.
- RGD analogs tolerated various side chain modifications, including amide, amine, ester, protected amine, and poly(ethylene glycol).
- An RGD analog with poly(ethylene glycol) modification retained high affinity for glycoprotein IIb/IIIa (IC50 = 150 nM).
Conclusions:
- RGD analogs can be effectively modified with various functional groups while maintaining high integrin receptor affinity.
- The successful modification with poly(ethylene glycol) suggests the feasibility of tethering large pharmaceutical agents.
- These modified RGD analogs show significant potential as versatile vectors for targeted drug delivery applications.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...